These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 32315723)

  • 1. Current epidemiological and clinical features of COVID-19; a global perspective from China.
    Tu H; Tu S; Gao S; Shao A; Sheng J
    J Infect; 2020 Jul; 81(1):1-9. PubMed ID: 32315723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
    Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
    Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
    Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
    Wang Y; Wang Y; Chen Y; Qin Q
    J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).
    Sohrabi C; Alsafi Z; O'Neill N; Khan M; Kerwan A; Al-Jabir A; Iosifidis C; Agha R
    Int J Surg; 2020 Apr; 76():71-76. PubMed ID: 32112977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.
    Wang L; Wang Y; Ye D; Liu Q
    Int J Antimicrob Agents; 2020 Jun; 55(6):105948. PubMed ID: 32201353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: The outbreak caused by a new coronavirus.
    Sifuentes-Rodríguez E; Palacios-Reyes D
    Bol Med Hosp Infant Mex; 2020; 77(2):47-53. PubMed ID: 32226003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.].
    Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI
    Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From SARS to COVID-19: What lessons have we learned?
    Liu Q; Xu K; Wang X; Wang W
    J Infect Public Health; 2020 Nov; 13(11):1611-1618. PubMed ID: 32888871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology and clinical information about COVID-19.
    Ge H; Wang X; Yuan X; Xiao G; Wang C; Deng T; Yuan Q; Xiao X
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1011-1019. PubMed ID: 32291542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver injury during highly pathogenic human coronavirus infections.
    Xu L; Liu J; Lu M; Yang D; Zheng X
    Liver Int; 2020 May; 40(5):998-1004. PubMed ID: 32170806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.